• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

CTLA4

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Regulatory T Cell function in cancer and inflammation

August 24, 2018Cancer, Cancer Immunotherapy, Featured, Inflammation, Microbiome, Vizit Graphs
Regulatory T Cell function in cancer and inflammation

Association of microbiome organisms to Regulatory T Cell function in cancer and inflammation. Explore the live graph.

Vizit Graphs Tag Cloud

CELL DIVISION LISTERIA MONOCYTOGENES BREAST CANCER CTLA4 CANDIDA ALBICANS APOPTOTIC PROCESS CASP3 CANCER IL17A AGING ESCHERICHIA COLI INSULIN PARKINSON DISEASE INFLAMMATION STAPHYLOCOCCUS AUREUS CELL DEATH NEURODEGENERATIVE DISORDERS TP53 IL6 STREPTOCOCCUS PNEUMONIAE CELL PROLIFERATION HELICOBACTER PYLORI AUTOPHAGY REMICADE FOXP3 ANGIOGENESIS ALZHEIMER'S DISEASE SOD1 TNF METFORMIN CLOSTRIDIUM DIFFICILE RECEPTOR CELL DIFFERENTIATION PORPHYROMONAS GINGIVALIS RHEUMATOID ARTHRITIS PSEUDOMONAS AERUGINOSA TH17 CELLS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE DOXORUBICIN DIABETES MELLITUS CD4 IL23A ERBB-2 IMMUNE RESPONSE IFNG

© 2019 Biovista Vizit All Rights Reserved.